Measles
📧 Sign up to get email alerts when something new happens for Measles.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Japanese Encephalitis Vaccine when administered with the MMR vaccine.
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients [Phase 4]
Phase 4 clinical trial update on inducing immunity against measles in pediatric liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella [Phase 2, Phase 3]
A Phase 2/3 trial evaluated immunogenicity, reactogenicity, and safety of a double viral vaccine for measles and rubella. The study has comp…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine [Phase 4]
Phase 4 trial update evaluating safety and immunogenicity of measles, varicella, and hepatitis A vaccines.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) [Phase 2, Phase 3]
Clinical trial update reporting immunogenicity and safety data for Bio Farma's measles-rubella vaccine in Indonesian infants, bridging Phase…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [Phase 3]
Phase 3 study comparing frozen versus refrigerated MMRV vaccine (V221-016) completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children [Phase 4]
Phase 4 clinical trial update on reactogenicity and immunogenicity after measles-rubella routine immunization in Indonesian infants and chil…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Coadministration of Measles-rubella and Rotavirus Vaccines [Phase 4]
Phase 4 trial update evaluating coadministration of measles-rubella and rotavirus vaccines with results completed and posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age [Phase 4]
This Phase 4 trial update reports results on coadministering a live attenuated Japanese encephalitis vaccine with a measles vaccine in 9-mon…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III) [Phase 3]
Phase III clinical trial update for a measles-rubella combined vaccine (MRVAC) produced by POLYVAC; the study is completed.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life [Phase 3]
Phase 3 trial update on the immunogenicity and safety of GSK's combined MMR vaccine in children in their second year of life; results posted…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: ProQuad® Intramuscular vs Subcutaneous [Phase 3]
Phase 3 trial comparing ProQuad intramuscular vs subcutaneous administration in measles/mumps rubella/varicella indications; results posted …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age [Phase 3]
A Phase 3 trial comparing GSK's MMR vaccine to Merck's MMR vaccine in healthy children 12 to 15 months old; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age [Phase 3]
A Phase 3 consistency study comparing GSK's MMR vaccine (Priorix) with Merck's M-M-R II in children 12 to 15 months, assessing immunogenicit…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children [Phase 4]
A Phase 4 trial assessing the safety and immunogenicity of the Measles-Mumps-Rubella vaccine delivered by a needle-free DSJI device compared…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) [Phase 3]
A Phase 3 comparative study evaluating immunogenicity and safety of a two-dose Regimen of ProQuad manufactured with rHA (V221-038) for measl…
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination
Update describing the completed study and results of a specified drug-use survey of vaccinees after the second dose of Takeda's freeze-dried…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Safety Study of ProQuad® rHA in Infants (V221-037) [Phase 3]
Phase 3 safety study of ProQuad rHA in infants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [Phase 2]
Phase 2 immunogenicity and safety study of GSK's 208136 vaccine formulated with new seed strains for measles and rubella; results posted aft…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [Phase 3]
Phase 3 trial comparing GSK's MMRV vaccine to Priorix; the study is completed and results were posted on 2017-09-25.
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of GSK's combined MMR vaccine in children aged four to six years has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine [Phase 4]
A Phase 4 trial sponsored by the Centers for Disease Control and Prevention, China, evaluated the immunization schedule for Beijing Tiantan …
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [Phase 3]
Phase 3 immunogenicity and safety study of GlaxoSmithKline's combined measles-mumps-rubella-varicella vaccine has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's combined measles-mumps-rubella vaccine in volunteers aged seven …